The Ripoptosome, a signaling platform that assembles in response to genotoxic stress and loss of IAPs.

A better understanding of the mechanisms through which anticancer drugs exert their effects is essential to improve combination therapies. While studying how genotoxic stress kills cancer cells, we discovered a large ∼2MDa cell death-inducing platform, referred to as "Ripoptosome." It contains the core components RIP1, FADD, and caspase-8, and assembles ...
in response to genotoxic stress-induced depletion of XIAP, cIAP1 and cIAP2. Importantly, it forms independently of TNF, CD95L/FASL, TRAIL, death-receptors, and mitochondrial pathways. It also forms upon Smac-mimetic (SM) treatment without involvement of autocrine TNF. Ripoptosome assembly requires RIP1's kinase activity and can stimulate caspase-8-mediated apoptosis as well as caspase-independent necrosis. It is negatively regulated by FLIP, cIAP1, cIAP2, and XIAP. Mechanistically, IAPs target components of this complex for ubiquitylation and inactivation. Moreover, we find that etoposide-stimulated Ripoptosome formation converts proinflammatory cytokines into prodeath signals. Together, our observations shed new light on fundamental mechanisms by which chemotherapeutics may kill cancer cells.
Mesh Terms:
Antineoplastic Agents, Apoptosis, CASP8 and FADD-Like Apoptosis Regulating Protein, Caspase 8, Cell Line, Tumor, DNA Damage, Enzyme Activation, Etoposide, Fas-Associated Death Domain Protein, Humans, Inhibitor of Apoptosis Proteins, Ligands, Mitochondria, Nuclear Pore Complex Proteins, RNA-Binding Proteins, Signal Transduction
Mol. Cell
Date: Aug. 05, 2011
Download Curated Data For This Publication
124748
Switch View:
  • Interactions 6